Variables | Stage 1 (n = 532) | Stage 2 (n = 309) | Stage 3 (n = 560) | P value |
---|---|---|---|---|
Age (years) | 63.5 ± 16.6 | 61.7 ± 17.9 | 63.6 ± 17.3 | 0.292 |
Male (%) | 375 (70.5) | 309 (64.7) | 364 (65.0) | 0.097 |
eGFR (mL/min/1.73 m2) | 76.9 ± 31.9 | 81.4 ± 29.4 | 50.4 ± 39.3 | <0.001* |
Interval between admission and AKI diagnosed (days) | 6 (2,11) | 7 (3,14) | 3 (1,9) | <0.001* |
Diagnosis (%) | Â | Â | Â | <0.001* |
 Timely | 110 (20.7) | 76 (24.6) | 430 (76.8) |  |
 Delayed | 10 (1.9) | 14 (4.5) | 22 (3.9) |  |
 Missed | 412 (77.4) | 219 (70.9) | 108 (19.3) |  |
Only 2 SCr detection (%) | 38 (7.1) | 10 (3.2) | 11 (2.0) | <0.001* |
Renal prognosis at discharge (%) | Â | Â | Â | <0.001* |
 Completely recovery | 311 (58.5) | 171 (55.3) | 146 (26.1) |  |
 Partial recovery | 51 (9.6) | 42 (13.6) | 85 (15.2) |  |
 Loss of renal function | 38 (7.1) | 38 (12.3) | 245 (43.7) |  |
 No dataa | 132 (24.8) | 58 (18.8) | 84 (15.0) |  |
ICU stay (days) | 0 (0–2) | 0 (0–4) | 0 (0–9) | <0.001* |
Hospital stay (days) | 20.9 ± 18.1 | 24.3 ± 17.7 | 22.6 ± 22.2 | <0.001* |
Hospital costs (thousand CNY) | 53.5 (20.8–103.5) | 68.9 (33.4–132.9) | 54.4 (24.8–132.4) | <0.001* |
30-day mortality (%) | 121 (22.7) | 105 (34.0) | 269 (48.0) | <0.0001* |